Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 2
1954 1
1955 1
1956 1
1957 1
1960 1
1963 2
1964 5
1966 2
1968 1
1972 1
1975 1
1976 1
1999 2
2000 1
2001 1
2005 1
2006 1
2007 1
2008 1
2012 2
2014 1
2015 2
2017 3
2018 1
2019 1
2020 1
2021 1
2022 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Pro-Gastrin-Releasing Peptide as a Marker of Small Cell Lung Cancer.
Lyubimova NV, Kuz'minov AE, Markovich AA, Lebedeva AV, Timofeev YS, Stilidi IS, Kushlinskii NE. Lyubimova NV, et al. Among authors: markovich aa. Bull Exp Biol Med. 2022 Jun;173(2):257-260. doi: 10.1007/s10517-022-05529-9. Epub 2022 Jun 23. Bull Exp Biol Med. 2022. PMID: 35737164
Basal insulin and cardiovascular and other outcomes in dysglycemia.
ORIGIN Trial Investigators; Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. ORIGIN Trial Investigators, et al. N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11. N Engl J Med. 2012. PMID: 22686416 Free article. Clinical Trial.
[Survival predictors in patients with ectopic acth syndrome].
Golounina OO, Belaya ZE, Rozhinskaya LY, Pikunov MY, Markovich AA, Dzeranova LK, Marova EI, Kuznetsov NS, Fadeev VV, Melnichenko GA, Dedov II. Golounina OO, et al. Among authors: markovich aa. Probl Endokrinol (Mosk). 2022 Aug 15;68(6):30-42. doi: 10.14341/probl13144. Probl Endokrinol (Mosk). 2022. PMID: 36689709 Free PMC article. Russian.
Somatostatin receptor type 2 expression in Merkel cell carcinoma as a prognostic factor.
Orlova KV, Delektorskaya VV, Vishnevskaya YV, Kondratieva TT, Orel NF, Markovich AA, Demidov LV, Subramanian S. Orlova KV, et al. Among authors: markovich aa. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):e236-e237. doi: 10.1111/jdv.14769. Epub 2018 Jan 11. J Eur Acad Dermatol Venereol. 2018. PMID: 29265481 No abstract available.
Chromogranin B in blood serum of patients with neuroendocrine tumors.
Lyubimova NV, Timofeev YS, Markovich AA, Lebedeva AV, Karamisheva EI, Delektorskaya VV, Kushlinskii NE. Lyubimova NV, et al. Among authors: markovich aa. Klin Lab Diagn. 2022 Aug 15;67(8):440-443. doi: 10.51620/0869-2084-2022-67-8-440-443. Klin Lab Diagn. 2022. PMID: 36095079 English.
Long-term outcomes and survival predictors in patients with ectopic ACTH syndrome: data from a retrospective cohort study.
Belaya Z, Rozhinskaya L, Golounina O, Solodovnikov A, Marova E, Arapova S, Pikunov M, Markovich A, Mamedova E, Przhialkovskaya E, Pigarova E, Fadeev V, Kuznetsov N, Sitkin I, Dzeranova L, Lutsenko A, Mokrysheva N, Dedov I, Melnichenko G. Belaya Z, et al. Among authors: markovich a. Endocr Connect. 2025 Sep 22;14(9):e250411. doi: 10.1530/EC-25-0411. Print 2025 Sep 1. Endocr Connect. 2025. PMID: 40919707 Free PMC article.
45 results